Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

June 02, 2014

AstraZeneca AB v. Mylan Pharmaceuticals Inc.

Track this case

Case Number:

1:14-cv-00696

Court:

Delaware

Nature of Suit:

Patent

Judge:

Gregory M. Sleet

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. December 19, 2014

    Mylan Can Ask Fed. Circ. To Weigh Hatch-Waxman Jurisdiction

    A federal judge has allowed Mylan Pharmaceuticals Inc. to file an interlocutory appeal to the Federal Circuit of his decision that the company is subject to jurisdiction in Delaware in a suit over generic versions of AstraZeneca AB drugs, saying the case raises a novel issue in Hatch-Waxman law.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login